Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus	Kidney Transplant Recipient	Not yet recruiting	Phase 2 / Phase 3	2026-09-16		NCT06913023

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University Health Network, Toronto	417

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
St. Paul's Hospital	Vancouver	Canada	28
Toronto General Hospital	Toronto	Canada	13

Clinical trials